Toggle Main Menu Toggle Search

Open Access padlockePrints

Bi-allelic variants in MRPL49 cause variable clinical presentations, including sensorineural hearing loss, leukodystrophy, and ovarian insufficiency

Lookup NU author(s): Dr Monika Olahova, Dr Kyle Thompson, Dr Langping He, Professor Robert TaylorORCiD

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Abstract

© 2025 The Author(s). Combined oxidative phosphorylation deficiency (COXPD) is a rare multisystem disorder that is clinically and genetically heterogeneous. Genome sequencing identified bi-allelic MRPL49 variants in individuals from nine unrelated families with presentations ranging from Perrault syndrome (primary ovarian insufficiency and sensorineural hearing loss) to severe childhood onset of leukodystrophy, learning disability, microcephaly, and retinal dystrophy. Complexome profiling of fibroblasts from affected individuals revealed reduced levels of the small mitochondrial ribosomal subunits and a more pronounced reduction of the large mitochondrial ribosomal subunits. There was no evidence of altered mitoribosomal assembly. The reductions in levels of oxidative phosphorylation (OXPHOS) enzyme complexes I and IV are consistent with a form of COXPD associated with bi-allelic MRPL49 variants, expanding the understanding of how disruption of the mitochondrial ribosomal large subunit results in multisystem phenotypes.


Publication metadata

Author(s): Thomas HB, Demain LAM, Cabrera-Orefice A, Schrauwen I, Shamseldin HE, Rea A, Bharadwaj T, Smith TB, Olahova M, Thompson K, He L, Kaur N, Shukla A, Abukhalid M, Ansar M, Rehman S, Riazuddin S, Abdulwahab F, Smith JM, Stark Z, Mancilar H, Tumer S, Esen FN, Uctepe E, Topcu V, Yesilyurt A, Afzal E, Salari M, Carroll C, Zifarelli G, Bauer P, Kor D, Bulut FD, Houlden H, Maroofian R, Carrera S, Yue WW, Munro KJ, Alkuraya FS, Jamieson P, Ahmed ZM, Leal SM, Taylor RW, Wittig I, O'Keefe RT, Newman WG

Publication type: Article

Publication status: Published

Journal: American Journal of Human Genetics

Year: 2025

Volume: 112

Issue: 4

Pages: 952-962

Print publication date: 03/04/2025

Online publication date: 04/03/2025

Acceptance date: 06/02/2025

Date deposited: 10/04/2025

ISSN (print): 0002-9297

ISSN (electronic): 1537-6605

Publisher: Cell Press

URL: https://doi.org/10.1016/j.ajhg.2025.02.005

DOI: 10.1016/j.ajhg.2025.02.005

Data Access Statement: The MRPL49 variants were submitted to ClinVar (https://www.ncbi.nlm.nih.gov/clinvar/) (GenBank: NM_004927.4; accession numbers SCV004242144–SCV004242147). The exome datasets supporting this study have not been deposited in a public repository because of ethical restrictions but are available from the corresponding author upon request. The mass spectrometry data have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository with the dataset identifier PXD056347 and 10.6019/PXD056347.

PubMed id: 40043708


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
203105/Z/16/ZWellcome Trust
Action Medical Research (GN2494)
Action on Hearing Loss (S35 and S60_Newman)
Deutsche Forschungsgemeinschaft (DFG)
Medical Research Council (MR/W019027/1)
Lily Foundation
National Institute for Health Research through the Comprehensive Clinical Research Network
NIH-National Institute of Child Health and Human Development (NICHD) (R01HD109342)
NIDCD/NIH (R01DC012564)
NIHR Manchester Biomedical Research Centre (IS-BRC-1215-20007 and NIHR203308)
UK NHS Highly Specialised "Rare Mitochondrial Disorders of Adults and Children" Service

Share